Literature DB >> 16849496

CXCR3 and IFN protein-10 in Pneumocystis pneumonia.

Florencia McAllister1, Sanbao Ruan, Chad Steele, Mingquan Zheng, Laura McKinley, Lauren Ulrich, Luis Marrero, Judd E Shellito, Jay K Kolls.   

Abstract

We have previously shown that Tc1 CD8(+) T cells have in vitro and in vivo effector activity against Pneumocystis (PC) infection in mice. Because these cells have preferential expression of CXCR3, we investigated whether CXCR3 was required for host defense activity against PC. Mice deficient in CXCR3 but CD4(+) T cell intact, showed an initial delay but were able to clear the infectious challenge, indicating that CXCR3 signaling is not essential for clearance of PC. CD4-depleted mice had lower levels of monokine induced by IFN-gamma, IFN protein-10 (IP-10), and IFN-inducible T cell alpha-chemoattractant at day 7 of infection and are permissive to PC infection. Overexpression of IP-10 in the lungs by adenoviral gene transfer did not accelerate clearance of infection in control mice but accelerated clearance by day 28 in mice depleted of CD4(+) T cells. This effect was associated with increased recruitment of CD8(+) T to the lungs with higher CXCR3(+) expression levels and enhanced IFN-gamma secretion upon in vitro activation compared with control mice. These results indicate that the CXCR3 chemokines are part of the host defense response to PC, and that IP-10 can direct Tc1 CD8(+) T cell recruitment to the lungs and contribute to host defense against PC even in the absence of CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849496      PMCID: PMC3912555          DOI: 10.4049/jimmunol.177.3.1846

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

Review 1.  Chemokines. Introduction and overview.

Authors:  A Mantovani
Journal:  Chem Immunol       Date:  1999

2.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.

Authors:  S Qin; J B Rottman; P Myers; N Kassam; M Weinblatt; M Loetscher; A E Koch; B Moser; C R Mackay
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

Authors:  H Furrer; M Egger; M Opravil; E Bernasconi; B Hirschel; M Battegay; A Telenti; P L Vernazza; M Rickenbach; M Flepp; R Malinverni
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

5.  CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions.

Authors:  K E Balashov; J B Rottman; H L Weiner; W W Hancock
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells.

Authors:  J K Kolls; S Habetz; M K Shean; C Vazquez; J A Brown; D Lei; P Schwarzenberger; P Ye; S Nelson; W R Summer; J E Shellito
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

7.  In vitro effector activity of Pneumocystis murina-specific T-cytotoxic-1 CD8+ T cells: role of granulocyte-macrophage colony-stimulating factor.

Authors:  Florencia McAllister; Chad Steele; Mingquan Zheng; Judd E Shellito; Jay K Kolls
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice.

Authors:  Florencia McAllister; Florencia Mc Allister; Chad Steele; Mingquan Zheng; Erana Young; Judd E Shellito; Luis Marrero; Jay K Kolls
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

Review 9.  Current epidemiology of Pneumocystis pneumonia.

Authors:  Alison Morris; Jens D Lundgren; Henry Masur; Peter D Walzer; Debra L Hanson; Toni Frederick; Laurence Huang; Charles B Beard; Jonathan E Kaplan
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

10.  Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor.

Authors:  Chad Steele; Luis Marrero; Steve Swain; Allen G Harmsen; Mingquan Zheng; Gordon D Brown; Siamon Gordon; Judd E Shellito; Jay K Kolls
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  18 in total

1.  Experimental Pneumocystis lung infection promotes M2a alveolar macrophage-derived MMP12 production.

Authors:  Michael P Nelson; Benjamin S Christmann; Chad W Dunaway; Alison Morris; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-06       Impact factor: 5.464

2.  Acute respiratory distress syndrome: new definition, current and future therapeutic options.

Authors:  Vito Fanelli; Aikaterini Vlachou; Shirin Ghannadian; Umberto Simonetti; Arthur S Slutsky; Haibo Zhang
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 3.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 4.  Gene therapy for ALI/ARDS.

Authors:  Xin Lin; David A Dean
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

5.  γδ T cells attenuate bleomycin-induced fibrosis through the production of CXCL10.

Authors:  Derek A Pociask; Kong Chen; Sun Mi Choi; Tim D Oury; Chad Steele; Jay K Kolls
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

6.  Characterization of chemokine and chemokine receptor expression during Pneumocystis infection in healthy and immunodeficient mice.

Authors:  Lisa R Bishop; Michail S Lionakis; Monica Sassi; Philip M Murphy; Xiaojun Hu; Da Wei Huang; Brad Sherman; Ju Qiu; Jun Yang; Richard A Lempicki; Joseph A Kovacs
Journal:  Microbes Infect       Date:  2015-06-05       Impact factor: 2.700

Review 7.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

8.  Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina.

Authors:  Michelle N Kelly; Mingquan Zheng; Sanbao Ruan; Jay Kolls; Alain D'Souza; Judd E Shellito
Journal:  J Immunol       Date:  2012-11-30       Impact factor: 5.422

9.  Interleukin-12 and host defense against murine Pneumocystis pneumonia.

Authors:  Sanbao Ruan; Laura McKinley; Mingquan Zheng; Xiaowen Rudner; Alain D'Souza; Jay K Kolls; Judd E Shellito
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

10.  Lymphocyte apoptosis in murine Pneumocystis pneumonia.

Authors:  Xin Shi; Nicole J LeCapitaine; Xiaowen L Rudner; Sanbao Ruan; Judd E Shellito
Journal:  Respir Res       Date:  2009-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.